478 related articles for article (PubMed ID: 32021563)
1. ALKBH5-mediated m
Chen S; Zhou L; Wang Y
Cancer Cell Int; 2020; 20():34. PubMed ID: 32021563
[TBL] [Abstract][Full Text] [Related]
2. ALKBH5 regulates STAT3 activity to affect the proliferation and tumorigenicity of osteosarcoma via an m6A-YTHDF2-dependent manner.
Yang Z; Cai Z; Yang C; Luo Z; Bao X
EBioMedicine; 2022 Jun; 80():104019. PubMed ID: 35490460
[TBL] [Abstract][Full Text] [Related]
3. The RNA demethylase ALKBH5 promotes the progression and angiogenesis of lung cancer by regulating the stability of the LncRNA PVT1.
Shen W; Pu J; Zuo Z; Gu S; Sun J; Tan B; Wang L; Cheng J; Zuo Y
Cancer Cell Int; 2022 Nov; 22(1):353. PubMed ID: 36376862
[TBL] [Abstract][Full Text] [Related]
4. LINC00659 cooperated with ALKBH5 to accelerate gastric cancer progression by stabilising JAK1 mRNA in an m
Fang Y; Wu X; Gu Y; Shi R; Yu T; Pan Y; Zhang J; Jing X; Ma P; Shu Y
Clin Transl Med; 2023 Mar; 13(3):e1205. PubMed ID: 36864711
[TBL] [Abstract][Full Text] [Related]
5. ALKBH5 regulates ovarian cancer growth via demethylating long noncoding RNA PVT1 in ovarian cancer.
Li L; Chen J; Wang A; Yi K
J Cell Mol Med; 2024 Jan; 28(2):e18066. PubMed ID: 38098223
[TBL] [Abstract][Full Text] [Related]
6. RNA demethylase ALKBH5 promotes colorectal cancer progression by posttranscriptional activation of RAB5A in an m6A-YTHDF2-dependent manner.
Shen D; Lin J; Xie Y; Zhuang Z; Xu G; Peng S; Tang G; Bai L; Zhu M; Zhang Y; Huang Z; Wang P; Liu X; Huang M; Luo Y; Wang X; Yu H
Clin Transl Med; 2023 May; 13(5):e1279. PubMed ID: 37203239
[TBL] [Abstract][Full Text] [Related]
7. ALKBH5-mediated m6A modification of lncRNA KCNQ1OT1 triggers the development of LSCC via upregulation of HOXA9.
Li Y; Yan B; Wang X; Li Q; Kan X; Wang J; Sun Y; Wang P; Tian L; Liu M
J Cell Mol Med; 2022 Jan; 26(2):385-398. PubMed ID: 34850551
[TBL] [Abstract][Full Text] [Related]
8. RNA demethylase ALKBH5 prevents pancreatic cancer progression by posttranscriptional activation of PER1 in an m6A-YTHDF2-dependent manner.
Guo X; Li K; Jiang W; Hu Y; Xiao W; Huang Y; Feng Y; Pan Q; Wan R
Mol Cancer; 2020 May; 19(1):91. PubMed ID: 32429928
[TBL] [Abstract][Full Text] [Related]
9. ALKBH5-mediated m
Huang X; Zhao Y; Liu D; Gu S; Liu Y; Khoong Y; Luo S; Zhang Z; Xia W; Wang M; Liang H; Li M; Li Q; Zan T
Inflamm Regen; 2023 Jul; 43(1):36. PubMed ID: 37452367
[TBL] [Abstract][Full Text] [Related]
10. Long non-coding RNA PVT1 (PVT1) affects the expression of CCND1 and promotes doxorubicin resistance in osteosarcoma cells.
Li Z; Tian JM; Chu Y; Zhu HY; Wang JJ; Huang J
J Bone Oncol; 2023 Dec; 43():100512. PubMed ID: 38021073
[TBL] [Abstract][Full Text] [Related]
11. ALKBH5 suppresses malignancy of hepatocellular carcinoma via m
Chen Y; Zhao Y; Chen J; Peng C; Zhang Y; Tong R; Cheng Q; Yang B; Feng X; Lu Y; Xie H; Zhou L; Wu J; Zheng S
Mol Cancer; 2020 Aug; 19(1):123. PubMed ID: 32772918
[TBL] [Abstract][Full Text] [Related]
12. Bioactive peptide inhibits acute myeloid leukemia cell proliferation by downregulating ALKBH5-mediated m
Zhang L; Su X
Cell Oncol (Dordr); 2022 Jun; 45(3):355-365. PubMed ID: 35579750
[TBL] [Abstract][Full Text] [Related]
13. Demethylase ALKBH5 suppresses invasion of gastric cancer via PKMYT1 m6A modification.
Hu Y; Gong C; Li Z; Liu J; Chen Y; Huang Y; Luo Q; Wang S; Hou Y; Yang S; Xiao Y
Mol Cancer; 2022 Feb; 21(1):34. PubMed ID: 35114989
[TBL] [Abstract][Full Text] [Related]
14. METTL14-mediated epitranscriptome modification of MN1 mRNA promote tumorigenicity and all-trans-retinoic acid resistance in osteosarcoma.
Li HB; Huang G; Tu J; Lv DM; Jin QL; Chen JK; Zou YT; Lee DF; Shen JN; Xie XB
EBioMedicine; 2022 Aug; 82():104142. PubMed ID: 35810559
[TBL] [Abstract][Full Text] [Related]
15. ALKBH5 promotes the proliferation of renal cell carcinoma by regulating AURKB expression in an m
Zhang X; Wang F; Wang Z; Yang X; Yu H; Si S; Lu J; Zhou Z; Lu Q; Wang Z; Yang H
Ann Transl Med; 2020 May; 8(10):646. PubMed ID: 32566583
[TBL] [Abstract][Full Text] [Related]
16. ALKBH5 promotes invasion and metastasis of gastric cancer by decreasing methylation of the lncRNA NEAT1.
Zhang J; Guo S; Piao HY; Wang Y; Wu Y; Meng XY; Yang D; Zheng ZC; Zhao Y
J Physiol Biochem; 2019 Aug; 75(3):379-389. PubMed ID: 31290116
[TBL] [Abstract][Full Text] [Related]
17. ALKBH5-Modified HMGB1-STING Activation Contributes to Radiation Induced Liver Disease via Innate Immune Response.
Chen G; Zhao Q; Yuan B; Wang B; Zhang Y; Li Z; Du S; Zeng Z
Int J Radiat Oncol Biol Phys; 2021 Oct; 111(2):491-501. PubMed ID: 34044094
[TBL] [Abstract][Full Text] [Related]
18. ALKBH5-HOXA10 loop-mediated JAK2 m6A demethylation and cisplatin resistance in epithelial ovarian cancer.
Nie S; Zhang L; Liu J; Wan Y; Jiang Y; Yang J; Sun R; Ma X; Sun G; Meng H; Xu M; Cheng W
J Exp Clin Cancer Res; 2021 Sep; 40(1):284. PubMed ID: 34496932
[TBL] [Abstract][Full Text] [Related]
19. ALKBH5-mediated N
Song W; Fei F; Qiao F; Weng Z; Yang Y; Cao B; Yue J; Xu J; Zheng M; Li J
Cell Death Discov; 2022 Jan; 8(1):25. PubMed ID: 35031597
[TBL] [Abstract][Full Text] [Related]
20. Knockdown of long noncoding RNA PVT1 suppresses cell proliferation and invasion of colorectal cancer via upregulation of microRNA-214-3p.
Shang AQ; Wang WW; Yang YB; Gu CZ; Ji P; Chen C; Zeng BJ; Wu JL; Lu WY; Sun ZJ; Li D
Am J Physiol Gastrointest Liver Physiol; 2019 Aug; 317(2):G222-G232. PubMed ID: 31125260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
